Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001144204-17-034929
Filing Date
2017-06-29
Accepted
2017-06-29 17:05:08
Documents
4
Effectiveness Date
2017-06-29

Document Format Files

Seq Description Document Type Size
1 S-8 v469833_s8.htm S-8 73779
2 EXHIBIT 5.1 v469833_ex5-1.htm EX-5.1 10212
3 EXHIBIT 23.2 v469833_ex23-2.htm EX-23.2 1378
4 GRAPHIC image_002.jpg GRAPHIC 2450
  Complete submission text file 0001144204-17-034929.txt   90012
Mailing Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922
Business Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922 908-517-7330
Cyclacel Pharmaceuticals, Inc. (Filer) CIK: 0001130166 (see all company filings)

EIN.: 911766850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-219055 | Film No.: 17939241
SIC: 2834 Pharmaceutical Preparations